Are you interested in studying liver diseases? Our research platform “Health Outcomes and Risk Assessment in Chronic Liver Disease” (HERALD) constitutes a unique blend of data on healthcare visits in primary and specialty care, prescriptions, lab values, FibroScan data, information […]
Whats your 5k PB? Last week members of our Stockholm office participated in Convinistafetten, Swedens biggest relay race. Our teams Quantifly, Quantimax and Quantifast flew past the beautiful scenery of Djurgården, and […]
What defines a good day at work for Mathias Lilja, #LeadAnalyst at Quantify in Stockholm? It seems #pingpong and advanced #programming is the perfect kombo. Get to know Mathias […]
Does it matter whether you use a clinical registry or administrative database to calculate drug persistence rates?
The answer is yes! Colleagues from The Janssen Pharmaceutical Companies of Johnson & Johnson, Quantify Research and our […]
A big shout out to our Fun Task Force for arranging an epic Summer Party at Södra Teatern last night. Great food, funny poetry, lots of singing and dancing in the bright […]
Quantify is the leading provider of Nordic RWE, but we are also increasingly being asked to coordinate RWE studies beyond the Nordic countries. Quantify has started a European RWE collaboration with Boehringer Ingelheim to conduct studies in heart […]
Quantify’s Christoph Abé (PhD) was involved in a large-scale study identifying population-level brain changes related to stock market fluctuations using neuroimaging data from the UK Biobank.
The study, published in Nature: Scientific Reports, […]
Want to know more about one of our recent publications? Quantify’s Kirk Geale, Gustaf Ortsäter and Alexander Rieem Dun are co-authors on a recent publication on ”Care Pathways in Atopic Dermatitis”. The study´s objective was to describe […]
